• Log in
  • Register
  • Subscribe
  • Contact Us
ISSN 1933-0863 (PRINT) ISSN 1933-0871 (ONLINE)
  • Home
  • About Journal
    • Aim & Scope
    • Editorial Board
    • Advertising
    • Contact
  • Contents
    • Latest Issue
    • Archives
  • Guidelines
    • Submission Guidelines
    • Peer Review
    • Policies
    • CopyRights
    • Permissions
    • Free Access
    • Ethics
one
piRNAs and PIWI-Like Proteins in Renal Cell Carcinoma
two
Upregulation of C1QTNF1 is associated with poor prognosis & immune cell infiltration
three
Kidney Cancer Research Highlights from IKCS 2024 Meeting
four
ASCO 2024 - Recommended Abstracts
five
A Look at the Evolving Kidney Cancer Landscape
LATEST CONTENTS
  • Editor Note >
    Driving Change in in RCC: Insights from ASCO GU 2025

    Thomas E. Hutson.

    Show full content
    Review
  • GU25 Summary >
    Driving Change in in RCC: Insights from ASCO GU 2025

    Marc Matrana.

    Show full content
    Review
  • Editor Note >
    Analysis of the effectiveness and safety of Tumor Treating Fields

    Xie Wantao.

    Show full content
    Review
  • Editor Note >
    KC Journal Club

    Thomas E. Hutson.

    Show full content
    Review
  • Editor Note >
    Medical Intelligence

    Thomas E. Hutson.

    Show full content
    Review
  • .......................................................................
  • ORIGINAL REVIEW
    piRNAs and PIWI-Like Proteins in RCC

    Reyes JS et al.

    Show full content
    Review
  • ORIGINAL RESEARCH
    Upregulation of C1QTNF1 is associated with poor prognosis & immune cell infiltration in KIRC

    Gu L et al.

    Show full content
    Review
  • .
  • EDITOR'S MEMO
    Editor's note

    Show full content
    Roundtable
  • IKCS24 Summary
    IKCS24 Conference Summary

    Show full content
    Roundtable
  • IKCS TOP 2024 Abstracts
    Kidney Cancer Research Highlights from 2024 IKCS Conference

    Show full content
    IKCS24 TOP
  • JOURNAL CLUB
    Journal club articles in kidney cancer research space/a>

    Show full content
    Roundtable
  • .....................
  • ORIGINAL REVIEW
    Kidney function decline in cT1a patients treated with Microwave Ablation Vs PN

    Jessica Qiu. et al.

    BACKGROUND: Microwave ablation (MWA) is an emerging treatment modality for clinical T1a (cT1a) small renal masses (SRM) with studies showing it has comparable oncological outcomes to partial nephrectomy (PN). However, more research is needed on the impact of each treatment on kidney function decline. .... Show full content
    Review
  • ORIGINAL REVIEW
    Minimally Invasive Kidney Surgery: Emerging Oncological Concerns

    Fletcher SA et al.

    Show full content
    Review
  • .
  • ESMO 2024 Abstract
    Kidney Cancer Research Highlights from 2024 ESMO Annual Meeting

    Yasser Ged and Nirmish Singla.

    Show full content
    ESMO2024
  • EDITOR'S MEMO
    Editor's note /a>

    Show full content
    Roundtable
  • JOURNAL CLUB
    Journal club articles in kidney cancer research space/a>

    Show full content
    Roundtable
  • MEDICAL INTELLIGENCE
    Medocal intelligence /a>

    Show full content
    Medical Intelligence
  • ORIGINAL REVIEW
    The Prognostic Value of Proteinuria Prior to Surgical Treatment of RCC

    Yong C. et al.

    Show full content
    Review
  • CASE STUDY
    CN Following Immunotherapy for mRCC and IVC Tumor Thrombus

    Fletcher SA et al.

    Show full content
    Review
  • .
  • ASCO 2024 Summary
    Kidney Cancer Research Highlights from 2024 ASCO Annual Meeting

    Yasser Ged and Nirmish Singla.

    Show full content
    Roundtable
  • EDITOR'S MEMO
    Editor's note /a>

    Show full content
    Roundtable
  • 2024 ASCO ABSTRACTS
    2024 ASCO - Recommended Abstracts

    Show full content
    Roundtable
  • JOURNAL CLUB
    Journal club articles in kidney cancer research space/a>

    Show full content
    Roundtable
  • MEDICAL INTELLIGENCE
    Medocal intelligence /a>

    Show full content
    Medical Intelligence
  • //////////////////////////////////////////////////////
  • ORIGINAL REVIEW
    Living with Metastatic Renal Cell Carcinoma: Survivorship Needs in the Combination Therapy Era

    Nikita V. Baclig et al.

    Show full content
    Roundtable
  • GU24 Summary
    Kidney Cancer Research Highlights from ASCO-GU 2024 Meeting

    Yasser Ged and Nirmish Singla.

    Show full content
    Roundtable
  • EDITOR'S MEMO
    Editor's note /a>

    Show full content
    Roundtable
  • GU24 ASCO ABSTRACTS
    GU 2024 ASCO - Recommended Abstracts

    Show full content
    Roundtable
  • JOURNAL CLUB
    Journal club articles in kidney cancer research space/a>

    Show full content
    Roundtable
  • MEDICAL INTELLIGENCE
    Medocal intelligence /a>

    Show full content
    Roundtable
  • -----------------------------------------------------------------------------------------------------
  • ORIGINAL RESEARCH
    Molecular and Immune Landscape of Fumarate Hydratase-mutated RCC

    Bayan Al-Share et al.

    Show full content
    Roundtable
  • COMMENTARY
    Commentary on "Molecular and Immune Landscape of Fumarate Hydratase-mutated RCC"

    Nirmish Singla, MD.

    Show full content
    Commentary
  • EDITOR'S NOTE
    Thomas E. Hutson, MD RCC"

    Show full content
    Editor Note
  • IKCS SUMMARY
    Neil J Shah, MD RCC"

    Show full content
    IKCS23 Summary
  • 2023 Annual Rounds Up
    Neil J Shah, MD RCC"

    Show full content
    IKCS23 Summary
  • Journal Club
    Neil J Shah, MD RCC"

    Show full content
    JC
  • MED INTEL
    medical intelligence RCC"

    Show full content
    medical intelligence
  • ORIGINAL REVIEW
    Cytoreductive Nephrectomy for mRCC – Current Concepts and Contentions in the Era of ICI

    Shapiro DD et al.

    Show full content
    Roundtable
  • ORIGINAL REVIEW
    Current perspective on the impact of endogenous retroviruses in ccRCC

    Gessner KH et al

    Show full content
     Gessner et al
  • REVIEW ARTICLE
    An Opportunity to Study Mechanisms of Palliative Care by Integrating into Management of RCC

    Patel HV et al

    Show full content
     Patel HV et al
  • Editorial Perspective
    HIF Pathway Inhibition hold much promise and Point Toward an expanding RCC Armamentarium

    Senthil Pazhanisamy

    Show full content
    Editorial
  • KCJ Medical Intelligence
    The latest breakthroughs and research updates in the renal cancer space

    --

    Show full content
    Editorial
  • ...........................
  • CASE STUDY
    An Opportunity to Study Mechanisms of Palliative Care by Integrating into Management of RCC

    Roy Elias, Yasser Ged, Nirmish Singla

    Show full content
    Campbell
  • RECOMMENDED ABSTRACTS
    Recommended Abstracts from ASCO23 in Renal Cancers

    Robert A. Figlin

    Show full content
    ASCO23 ABSTRACTS
  • ASCO23 Editorial
    ASCO 2023 Kidney Cancer Roundup

    Robert Figlin, MD

    Show full content
    Editorial
  • GU23 ASCO
    ASCO GU2023- Recommended Abstracts

    Robert A Figlin, MD

    Show full content
    ASCO GU23
  • CASE STUDY
    Ex-Vivo Partial Nephrectomy in a Solitary Kidney

    Rebecca A. Campbell et al.

    Show full content
    Roundtable
  • CASE STUDY
    Robotic-assisted cytoreductive partial nephrectomy for met-sarcomatoid RCC following dramatic response to combination IO therapy in a young female

    Bhanji Y et al

    Show full content
     Bhanji et al
  • ASCO23 coverage
    Kidney Cancer Updates from the 2023 ASCO Annual Meeting in Chicago.

    Roy Elias, Yasser Ged, Nirmish Singla

    Show full content
    ASCO23 SPL
  • RECOMMENDED ABSTRACTS
    Recommended Abstracts from ASCO23 in Renal Cancers

    Robert A. Figlin

    Show full content
    ASCO23 ABSTRACTS
  • ASCO23 Editorial
    ASCO 2023 Kidney Cancer Roundup

    Robert Figlin, MD

    Show full content
    Editorial
  • GU23 ASCO
    ASCO GU2023- Recommended Abstracts

    Robert A Figlin, MD

    Show full content
    ASCO GU23
  • CASE STUDY
    Successful Management of Metastatic Chromophobe RCC with NIVO + IPI

    Ravindra A, Dahmoush L, Rohan Garje R*

    Show full content
    Roundtable
  • REVIEW
    ICIs in RCC: Examining the Impact of Nutritional Status, Inflammation, & Body Composition

    Edouard H. Nicaise et al

    Show full content
    Roundtable
  • ASCO GU23 coverage
    Abstracts Highlight Progress in the Fight Against Kidney Cancer - GU ASCO 2023

    Arpita Desai, MD

    Show full content
    Roundtable
  • Editor's Memo
    Practice-Changing Cancer Trials Take Center Stage at the ASCO GU 2023

    Robert A. Figlin

    Show full content
    Editor's Memo
  • GU23 ASCO
    ASCO GU2023- Recommended Abstracts

    Robert A Figlin, MD

    Show full content
    ASCO GU23
  • OBITUARY
    Remembering Dr. Nicholas Vogelzang, MD

    Show full content
    Roundtable
  • ORIGINAL RESEARCH
    Exploring Treatment-Free Survival with Checkpoint Inhibitors

    Grayce N. Selig, MD1 Christopher J. Hoimes, DO,2 Joe Bible, PhD,3 Daniel J. George, MD,2 Michael R. Harrison, MD2

    Show full content
    Roundtable
  • Editorial Perspective
    A 20-year retrospective: How Kidney Cancer Journal Reflected on Advances in The Therapeutic Strategies

    Robert A Figlin, MD, FACP1 , Senthil Pazhanisamy, PhD

    Show full content
    Editoial Perspective
  • Editor's Memo
    2022 ESMO: Promise and Pitfalls of Adjuvant Immunotherapy

    Robert. A. Figlin, MD

    Show full content
    Roundtable
  • KCJ - ESMO22 SPECIAL

  • ESMO22 ABSTRACTS

    ESMO22 - Recommended Abstracts in Renal Cancers

    Robert A. Figlin, MD

    Show full content
    ESMO22 - Recommended Abstracts in Renal Cancers by Robert Figlin, MD
  • Journal Club

    Journal Club

    Robert A. Figlin, MD

    Show full content
    Journal Club
  • Expert Roundtable
    Recent Advances in Tivozanib plus Nivolumab Combinatorial Strategies in aRCC

    Motzer RJ, Choueiri TK, Albiges L & Figlin RA

    Show full content
    Roundtable
  • Original Contribution
    Comparison of Papillary Renal Cell Carcinoma Type 1 and Type 2

    Paquin M, Fasolino T, Bible J, Steck MB, Williams J.

    Show full content
    Original Contribution
  • Review Article
    Engineered T-Cell Therapy: The Next Direction for RCC Immuno-oncology?

    JJ H. Zhang, Neal A. Patel, Alexandra Drakaki, Allan J. Pantuck,*

    Show full content
    Roundtable
  • KCJ - ASCO22 SPECIAL

  • ASCO22-Editor's Memo

    ASCO22-Editor's Memo

    Robert A. Figlin, MD

    Show full content
    ASCO22-Editor's Note by Robert Figlin, MD
  • ASCO22 Session

    ASCO22 - RECOMMENDED ABSTRACTS IN KIDNEY CANCER

    Robert A. Figlin, MD

    Show full content
    ASCO22-Abstracts Robert Figlin, MD
  • ASCO22 Meeting HIGHLIGHTS

    Kidney Cancer Research Highlights from ASCO 2022

    Yasser Ged, Nirmish Singla

    Show full content
    Kidney Cancer Research Highlights from
ASCO 2022
  • Original Research
    The Latinx Disparity in Surgery for Kidney Cancer: Data from The South Texas Region

    Dursun F, Patel SR.....Kaushik D

    Show full content
    Original Contribution
  • Roundtable
    Recent Advances in BEMPEG (NKTR-214) plus NIVOLUMAB Combination Strategies in Advanced Renal Cell Carcinoma

    Nizar M. Tannir, Arlene O. Siefker-Radtke, Robert A. Figlin,

    Show full content
    Roundtable
  • Review Article
    Moving Beyond BMI – Developments in Body Composition and Muscle Measurement in RCC

    Dzimitrowicz H.....Harrison MR

    Roundtable
  • ASCO GU22 Coverage
    Kidney Cancer Research Highlights from ASCO GU 2022 Meeting

    Yasser Ged, Nirmish Singla.

    Show full content
    GU22 ASCO Coverage
  • ASCO GU22 Coverage
    ASCO GU22 – Kidney Cancer Highlights

    Jeffrey Graham, MD

    Show full content
    GU22 ASCO Coverage
  • Editor's Memo

    ROBERT A. FIGLIN, MD

    Show full content
    Editor Memo
  • GU22 ASCO Coverage

    - Important Abstracts

    Show full content
    GU22 Abstracts
  • -- Previous Issue --

  • IN MEMORIAM
    A Tribute to Dr. Christopher G. Wood, MD

    Dr. Nizar M. Tannir, MD, FACP

    Show full content
    A TRIBUTE TO DR. WOOD
  • Original Contribution
    Radiological Correlates of pT3a Kidney Cancer: Importance of Irregular Tumor Sinus Border

    Yunlin Ye*, Diego Aguilar Palaciosa, Rebecca Campbell et al.

    Show full content
    ORIGINAL CONTRIBUTION
  • COMMENTARY
    How Can We Predict pT3a Kidney Cancer and What Does It Mean?

    Nirmish Singla, MD.

    Show full content
    Commentary
  • IKCS 2021 COVERAGE
    IKCS 2021: Moving Kidney Cancer Care Forward

    Marc Matrana, MD, FACP

    Show full content
    IKCS21 Coverage
  • TOP ABSTRACTS
    IKCS 2021: TOP ABSTRACTS

    Robert A Figlin, MD

    TOP ABSTRACTS

    Top Abstracts from IKCS 2021 conference have been picked by Dr. Robert A Figlin, MD. ...........Show full content
    IKCS 2021 Top Abstracts
  • KCJ JOURNAL CLUB

    KCJ Journal Club

    ...........Show full content
    Q&A with Sallie McAdoo
  • Original Contribution
    Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial

    Susan Halabi, Qian Yang, Andrea Carmack, Andrew J. Armstrong MD et al.

    Show full content
    ORIGINAL CONTRIBUTION
  • Expert Q&A
    The Pathway of Belzutifan, from clinical trials to clinical practice:

    A conversation with Dr. Ramaprasad Srinivasan, MD, PhD

    Show full content
    EXPERT Q&A
  • Review Article

    The Current and Evolving Therapeutic Paradigm in the Management of Metastatic Renal Cell Carcinoma

    Thomas Hutson, MD, Robert A. Figlin, MD, FACP

    Show full content
    Review article
  • Expert Perspectives

    Nicholas J. Vogelzang, MD, FASCO, FACP

    Dr. Vogelzang

    Show full content
    Expert Perspectives
  • KCJ Editor's Memo

    Robert A. Figlin MD

    Novel Combination Therapies Shake Up the Spectrum of Renal Cancer Treatment.....Show full content

    Editor Memo
  • Medical Intelligence

    " Show full content
    medintel21q1.php
  • Original Contribution

    Resource-efficient pooled sequencing expands translational impact in solid tumors

    Renzo G. DiNatale et al.

    Show full content
    ORIGINAL CONTRIBUTION
  • Roundtable Monograph

    Changes, Challenges and Opportunities in Cancer Care During the COVID-19 Era and Beyond

    Robert J. Motzer, MD, Eric A. Jonasch, MD,Bradley A. McGregor, MD, Robert A. Figlin, MD, FACP

    Show full content
    ROUNDTABLE MONOGRAPH
  • KCJ REVIEW ARTICLE

    Dissecting the role of lymphadenectomy in the management of renal cell carcinoma:past, present, and future

    Alain Kaldany, Zev R. Leopold, Juliana E. Kim, Hiren V. Patel, Arnav Srivastava, Alexandra L.Tabakin, Eric A. Singer

    Abstract

    Lymph node involvement in renal cell carcinoma (RCC) portends a poor prognosis. However, the role of lymph node dissection (LND) at the time of tumor resection is not fully understood. Given the paucity of high-quality evidence supporting or refuting the routine use of LND in RCC, further research is needed to shed light on this important topic........Show full content
    REVIEW ARTICLE
2024 IKCS Supplement
ASCO23 Supplement
Tweet #kidneycancerj
Tweets by KidneyCancerJ

Check out - Instagram Posts

View this post on Instagram

A post shared by Kidney Cancer Journal (@kidneycancerjournal)

  • About KCJ
    • About Us
    • Contact Us
    • Advertising Information
  • Author Section
    • Submission Guidelines
    • Editorial Board
    • Policies
    • Diversity Commitment
  • Journal Contents
    • Latest Issue
    • Previous Issues
    • Free Access
  • Patient Resources
    • Clinical Trial Basics
    • Patient Assistance Programs
    • NCCN guide
    • Covid19 and cancer Resources
  • Stay Connected
      • Facebook
      • Twitter
      • Instagram
      • Youtube
      • LinkedIn
      • Get Our Newsletter
×

Subscription Sign Up

Sign Up

Feel free to choose as many as you like.



Terms of Service *

© 2021-22 Kidney Cancer Journal. All rights Reserved

  • Terms of Service
  • Privacy Policy
  • Contact KCJ
ISSN 1933-0863 (PRINT)

ISSN 1933-0871 (ONLINE)